Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)

  1. Casas, R.
  2. Dietrich, F.
  3. Puente-Marin, S.
  4. Barcenilla, H.
  5. Tavira, B.
  6. Wahlberg, J.
  7. Achenbach, P.
  8. Ludvigsson, J.
Journal:
Acta Diabetologica

ISSN: 1432-5233,  0940-5429

Year of publication: 2022

Volume: 59

Issue: 5

Pages: 687-696

Type: Article

DOI: 10.1007/S00592-022-01852-9 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus